Protalix Biotherapeutics Inc. buy melinda
Start price
17.05.17
/
50%
€7.24
Target price
25.05.17
€9.00
Performance (%)
12.85%
End price
25.05.17
€8.17
Summary
This prediction ended on 25.05.17 with a price of €8.17. The prediction had a final performance of 12.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | -6.160% | -6.160% | -30.229% | -15.095% |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
According to melinda what are the pros and cons of Protalix Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Israel
Stopped prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.56
28.12.25
28.12.25
-
28.12.26
28.12.26
-1.28%
03.01.26
03.01.26
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
27.12.23
27.12.23
€2.00
27.12.24
27.12.24
9.02%
28.12.24
28.12.24
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.96
02.06.16
02.06.16
€12.00
02.12.16
02.12.16
-22.13%
02.12.16
02.12.16
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€32.52
23.09.13
23.09.13
€40.00
24.03.14
24.03.14
2.15%
24.03.14
24.03.14
Could be worthwhile Investment >10% per year